Ichor Medical Systems notes this collaboration builds on Ichor’s long-standing relationship with the Department of Defense (DoD) exploring the potential of electroporation-based delivery to increase the potency of a number of biodefense- and pandemic-related DNA vaccines.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
